Finding the root of the problem: The quest to identify melanoma stem cells

Frontiers in Bioscience - Scholar

Volumn 3 S, Issue 3, 2011, Pages 937-945

  Abel, Ethan V ^a   Aplin, Andrew E ^a  

^a THOMAS JEFFERSON UNIVERSITY   (United States)

Author keywords

Melanoma; Melanoma Propagating Cells; Review; Stem Cells; Tumor Initiating Cells

Indexed keywords

ABC TRANSPORTER; ADAPALENE; BIOLOGICAL MARKER; BREAST CANCER RESISTANCE PROTEIN; CD133 ANTIGEN; DOXORUBICIN; KRUPPEL LIKE FACTOR 4; MYC PROTEIN; NESTIN; OCTAMER TRANSCRIPTION FACTOR 4; TRANSCRIPTION FACTOR; TRANSCRIPTION FACTOR SOX2; GLYCOPROTEIN; INTERMEDIATE FILAMENT PROTEIN; LEUKOCYTE ANTIGEN; NERVE PROTEIN; PEPTIDE; TUMOR MARKER;

ARTICLE; ARTIFACT; CANCER RESISTANCE; CANCER STEM CELL; CELL POPULATION; HUMAN; HYPOTHESIS; MELANOMA; MELANOMA CELL; NONHUMAN; PROTEIN FUNCTION; TUMOR CELL; ANIMAL; METABOLISM; MOUSE; PHYSIOLOGY; REVIEW;

MUS;

ANIMALS; ANTIGENS, CD; ATP-BINDING CASSETTE TRANSPORTERS; GLYCOPROTEINS; INTERMEDIATE FILAMENT PROTEINS; MELANOMA; MICE; NEOPLASTIC STEM CELLS; NERVE TISSUE PROTEINS; PEPTIDES; TRANSCRIPTION FACTORS; TUMOR MARKERS, BIOLOGICAL;

EID: 80053092309     PISSN: 19450516     EISSN: 19450524     Source Type: Journal    
DOI: 10.2741/s198     Document Type: Article

References (54)

1. M. Al-Hajj, M. S. Wicha, A. Benito-Hernandez, S. J. Morrison and M. F. Clarke: Prospective identification of tumorigenic breast cancer cells. Proc Natl Acad Sci USA, 100, 3983-3988 (2003) (Pubitemid 36418143)
2. D. Bonnet and J. E. Dick: Human acute myeloid leukemia is organized as a hierarchy that originates from a primitive hematopoietic cell. Nat Med, 3, 730-737 (1997) (Pubitemid 27298715)
3. C. A. O'Brien, A. Pollett, S. Gallinger and J. E. Dick: A human colon cancer cell capable of initiating tumour growth in immunodeficient mice. Nature, 445, 106-110 (2007) (Pubitemid 46067310)
4. S. K. Singh, C. Hawkins, I. D. Clarke, J. A. Squire, J. Bayani, T. Hide, R. M. Henkelman, M. D. Cusimano and P. B. Dirks: Identification of human brain tumour initiating cells. Nature, 432, 396-401 (2004) (Pubitemid 39551674)
5. P. M. Jones and A. M. George: The ABC transporter structure and mechanism: perspectives on recent research. Cell Mol Life Sci, 61, 682-699 (2004) (Pubitemid 38446412)
6. N. Y. Frank, A. Margaryan, Y. Huang, T. Schatton, A. M. Waaga-Gasser, M. Gasser, M. H. Sayegh, W. Sadee and M. H. Frank: ABCB5-mediated doxorubicin transport and chemoresistance in human malignant melanoma. Cancer Res, 65, 4320-4333 (2005) (Pubitemid 40775671)
7. T. Schatton, G. F. Murphy, N. Y. Frank, K. Yamaura, A. M. Waaga-Gasser, M. Gasser, Q. Zhan, S. Jordan, L. M. Duncan, C. Weishaupt, R. C. Fuhlbrigge, T. S. Kupper, M. H. Sayegh and M. H. Frank: Identification of cells initiating human melanomas. Nature, 451, 345-349 (2008)
8. T. Schatton, U. Schutte, N. Y. Frank, Q. Zhan, A. Hoerning, S. C. Robles, J. Zhou, F. S. Hodi, G. C. Spagnoli, G. F. Murphy and M. H. Frank: Modulation of Tcell activation by malignant melanoma initiating cells. Cancer Res, 70, 697-708 (2010)
9. N. Y. Frank, S. S. Pendse, P. H. Lapchak, A. Margaryan, D. Shlain, C. Doeing, M. H. Sayegh and M. H. Frank: Regulation of progenitor cell fusion by ABCB5 Pglycoprotein, a novel human ATP-binding cassette transporter. J Biol Chem, 278, 47156-47165 (2003) (Pubitemid 37452302)
10. K. G. Chen, G. Szakács, J.-P. Annereau, F. Rouzaud, X.-J. Liang, J. C. Valencia, C. N. Nagineni, J. J. Hooks, V. J. Hearing and M. M. Gottesman: Principal expression of two mRNA isoforms (ABCB 5α and ABCB 5β) of the ATP-binding cassette transporter gene ABCB 5 in melanoma cells and melanocytes. Pigment Cell Res, 18, 102-112 (2005) (Pubitemid 40445046)
11. S. Heimerl, A. Bosserhoff, T. Langmann, J. Ecker and G. Schmitz: Mapping ATP-binding cassette transporter gene expression profiles in melanocytes and melanoma cells. Melanoma Res, 17, 265-273 (2007) (Pubitemid 47462218)
12. G. I. Keshet, I. Goldstein, O. Itzhaki, K. Cesarkas, L. Shenhav, A. Yakirevitch, A. J. Treves, J. Schachter, N. Amariglio and G. Rechavi: MDR1 expression identifies human melanoma stem cells. Biochem Biophys Res Comm, 368, 930-936 (2008)
13. E. Monzani, F. Facchetti, E. Galmozzi, E. Corsini, A. Benetti, C. Cavazzin, A. Gritti, A. Piccinini, D. Porro, M. Santinami, G. Invernici, E. Parati, G. Alessandri and C. A. M. La Porta: Melanoma contains CD133 and ABCG2 positive cells with enhanced tumourigenic potential. Eur J Cancer, 43, 935-946 (2007) (Pubitemid 46366698)
14. M. Belicchi, F. Pisati, R. Lopa, L. Porretti, F. Fortunato, M. Sironi, M. Scalamogna, E. A. Parati, N. Bresolin and Y. Torrente: Human skin-derived stem cells migrate throughout forebrain and differentiate into astrocytes after injection into adult mouse brain. J Neurosci Res, 77, 475-486 (2004) (Pubitemid 39006999)
15. S. V. Shmelkov, R. St.Clair, D. Lyden and S. Rafii: AC133/CD133/Prominin- 1. Int J Biochem Cell Biol, 37, 715-719 (2005) (Pubitemid 40202993)
16. J. Miki, B. Furusato, H. Li, Y. Gu, H. Takahashi, S. Egawa, I. A. Sesterhenn, D. G. McLeod, S. Srivastava and J. S. Rhim: Identification of putative stem cell markers, CD133 and CXCR4, in hTERT-immortalized primary nonmalignant and malignant tumor-derived human prostate epithelial cell lines and in prostate cancer specimens. Cancer Res, 67, 3153-3161 (2007) (Pubitemid 46724852)
17. G. Ferrandina, G. Bonanno, L. Pierelli, A. Perillo, Procoli A, A. Mariotti, M. Corallo, E. Martinelli, S. Rutella, A. Paglia, G. Zannoni, S. Mancuso and G. Scambia: Expression of CD133-1 and CD133-2 in ovarian cancer. Int J Gynecol Cancer, 18, 506-514 (2008) (Pubitemid 351668323)
18. M. H. Wright, A. M. Calcagno, C. D. Salcido, M. D. Carlson, S. V. Ambudkar and L. Varticovski: Brca1 breast tumors contain distinct CD44+/CD24- and CD133+ cells with cancer stem cell characteristics. Breast Cancer Res, 10, R10 (2008)
19. C. Michaloglou, L. C. Vredeveld, M. S. Soengas, C. Denoyelle, T. Kuilman, C. M. van der Horst, D. M. Majoor, J. W. Shay, W. J. Mooi and D. S. Peeper: BRAFE600-associated senescence-like cell cycle arrest of human naevi. Nature, 436, 720-724 (2005) (Pubitemid 41117276)
20. V. C. Gray-Schopfer, S. C. Cheong, H. Chong, J. Chow, T. Moss, Z. A. Abdel-Malek, R. Marais, D. Wynford-Thomasand D. C. Bennett: Cellular senescence in naevi and immortalisation in melanoma: a role for p16? Br J Cancer, 95, 496-505 (2006) (Pubitemid 44232559)
21. W. M. Klein, B. P. Wu, S. Zhao, H. Wu, A. J. P. Klein-Szanto and S. R. Tahan: Increased expression of stem cell markers in malignant melanoma. Mod Pathol, 20, 102-107 (2006)
22. P. Dalerba, S. J. Dylla, I.-K. Park, R. Liu, X. Wang, R. W. Cho, T. Hoey, A. Gurney, E. H. Huang, D. M. Simeone, A. A. Shelton, G. Parmiani, C. Castelli and M. F. Clarke: Phenotypic characterization of human colorectal cancer stem cells. Proc Natl Acad Sci, 104, 10158-10163 (2007) (Pubitemid 47175279)
23. D. Horst, L. Kriegl, J. Engel, T. Kirchner and A. Jung: Prognostic Significance of the cancer stem cell markers CD133, CD44, and CD166 in colorectal cancer. Cancer Invest, 27, 844-850 (2009)
24. Y. Amoh, M. Bouvet, L. Li, K. Tsuji, A. Moossa, K. Katsuoka and R. Hoffman: Visualization of nascent tumor angiogenesis in lung and liver metastasis by differential dual-color fluorescence imaging in nestin-linked-GFP mice. Clin Exp Metastasis, 23, 315-322 (2006) (Pubitemid 46197114)
25. Y. Amoh, M. Yang, L. Li, J. Reynoso, M. Bouvet, A. R. Moossa, K. Katsuoka and R. M. Hoffman: Nestin-linked green fluorescent protein transgenic nude mouse for imaging human tumor angiogenesis. Cancer Res., 65, 5352-5357 (2005) (Pubitemid 40827348)
26. A. Gilyarov: Nestin in central nervous system cells. Neurosci Behav Physiol, 38, 165-169 (2008)
27. K. Michalczyk and M. Ziman: Nestin structure and predicted function in cellular cytoskeletal organisation. Histol Histopathol. , 20, 665-671 (2005) (Pubitemid 40468283)
28. K. Tanabe, Y. Amoh, M. Kanoh, H. Takasu, N. Sakai, Y. Sato and K. Katsuoka: Prognostic significance of the hair follicle stem cell marker nestin in patients with malignant melanoma. Eur J Dermatol., 20, 283-288 (2010)
29. S. Brychtova, M. Fiuraskova, A. Hlobilkova, T. Brychta and J. Hirnak: Nestin expression in cutaneous melanomas and melanocytic nevi. J Cutan Pathol, 34, 370-375 (2007) (Pubitemid 46633338)
30. A. Fusi, S. Ochsenreither, A. Busse, A. Rietz and U. Keilholz: Stem cell marker nestin expression in peripheral blood of patients with melanoma. Br J Dermatol., [Epub ahead of print] (2010)
31. W. Kleeberger, G. S. Bova, M. E. Nielsen, M. Herawi, A.-Y. Chuang, J. I. Epstein and D. M. Berman: Roles for the stem cell associated intermediate filament nestin in prostate cancer migration and metastasis. Cancer Res., 67, 9199-9206 (2007) (Pubitemid 47535906)
32. P. M. Steinert, Y.-H. Chou, V. Prahlad, D. A. D. Parry, L. N. Marekov, K. C. Wu, S.-I. Jang and R. D. Goldman: A high molecular weight intermediate filament-associated protein in BHK-21 cells is nestin, a type VI intermediate filament protein. limited co-assembly in vitro to form heteropolymers with type III vimentin and type IV alpha - internexin. J Biol Chem., 274, 9881-9890 (1999)
33. F. Perosa, E. Favoino, M. A. Caragnano, M. Prete and F. Dammacco: CD20: A target antigen for immunotherapy of autoimmune diseases. Autoimmun Rev, 4, 526-531 (2005) (Pubitemid 41415764)
34. D. Fang, T. K. Nguyen, K. Leishear, R. Finko, A. N. Kulp, S. Hotz, P. A. Van Belle, X. Xu, D. E. Elder and M. Herlyn: A tumorigenic subpopulation with stem cell properties in melanomas. Cancer Res, 65, 9328-9337 (2005) (Pubitemid 41508000)
35. E. Quintana, M. Shackleton, M. S. Sabel, D. R. Fullen, T. M. Johnson and S. J. Morrison: Efficient tumour formation by single human melanoma cells. Nature, 456, 593-598 (2008)
36. M. A. Held, D. P. Curley, D. Dankort, M. McMahon, V. Muthusamy and M. W. Bosenberg: Characterization of melanoma cells capable of propagating tumors from a singlecCell. Cancer Res, 70, 388-397 (2010)
37. A. D. Boiko, O. V. Razorenova, M. van de Rijn, S. M. Swetter, D. L. Johnson, D. P. Ly, P. D. Butler, G. P. Yang, B. Joshua, M. J. Kaplan, M. T. Longaker and I. L. Weissman: Human melanoma-initiating cells express neural crest nerve growth factor receptor CD271. Nature, 466, 133-137 (2010)
38. M.-Y. Kim, T. Oskarsson, S. Acharyya, D. X. Nguyen, X. H.-F. Zhang, L. Nortonand J. Massagué: Tumor selfseeding by circulating cancer cells. Cell, 139, 1315-1326 (2009)
39. A. Roesch, M. Fukunaga-Kalabis, E. C. Schmidt, S. E. Zabierowski, P. A. Brafford, A. Vultur, D. Basu, P. Gimotty, T. Vogt and M. Herlyn: A temporarily distinct subpopulation of slow-cycling melanoma cells is required for continuous tumor growth. Cell, 141, 583-594 (2010)
40. J. Yu, M. A. Vodyanik, K. Smuga-Otto, J. Antosiewicz-Bourget, J. L. Frane, S. Tian, J. Nie, G. A. Jonsdottir, V. Ruotti, R. Stewart, Slukvin, II and J. A. Thomson: Induced pluripotent stem cell lines derived from human somatic cells. Science, 318, 1917-1920 (2007)
41. K. Takahashi and S. Yamanaka: Induction of pluripotent stem cells from mouse embryonic and adult fibroblast cultures by defined factors. Cell, 126, 663-676 (2006) (Pubitemid 44233629)
42. J. Utikal, N. Maherali, W. Kulalert and K. Hochedlinger: Sox2 is dispensable for the reprogramming of melanocytes and melanoma cells into induced pluripotent stem cells. J Cell Sci, 122, 3502-3510 (2009)
43. G. I. Keshet, I. Goldstein, O. Itzhaki, K. Cesarkas, L. Shenhav, A. Yakirevitch, A. J. Treves, J. Schachter, N. Amariglio and G. Rechavi: MDR1 expression identifies human melanoma stem cells. Biochem Biophys Res Commun, 368, 930-936 (2008)
44. L. Strizzi, D. E. Abbott, D. S. Salomon and M. J. C. Hendrix: Potential for Cripto-1 in defining stem cell-like characteristics in human malignant melanoma. Cell Cycle, 7, 1931-1935 (2008) (Pubitemid 352030336)
45. D. Zhuang, S. Mannava, V. Grachtchouk, W. H. Tang, S. Patil, J. A. Wawrzyniak, A. E. Berman, T. J. Giordano, E. V. Prochownik, M. S. Soengas and M. A. Nikiforov: CMYC overexpression is required for continuous suppression of oncogene-induced senescence in melanoma cells. Oncogene, 27, 6623-6634 (2008)
46. A. C. Laga, C.-Y. Lai, Q. Zhan, S. J. Huang, E. F. Velazquez, Q. Yang, M.-Y. Hsu and G. F. Murphy: Expression of the embryonic stem cell transcription factor SOX2 in human skin: Relevance to melanocyte and merkel cell biology. Am J Pathol., 176, 903-913 (2010)
47. M. Schoenhals, A. Kassambara, J. D. Vos, D. Hose, J. Moreaux and B. Klein: Embryonic stem cell markers expression in cancers. Biochem Biophys Res Comm, 383, 157-162 (2009)
48. L. A. Hanna, R. K. Foreman, I. A. Tarasenko, D. S. Kessler and P. A. Labosky: Requirement for Foxd3 in maintaining pluripotent cells of the early mouse embryo. Genes Dev, 16, 2650-2661 (2002)
49. R. Kos, M. V. Reedy, R. L. Johnson and C. A. Erickson: The winged-helix transcription factor FoxD3 is important for establishing the neural crest lineage and repressing melanogenesis in avian embryos. Development, 128, 1467-1479 (2001) (Pubitemid 32409665)
50. E. V. Abel and A. E. Aplin: FOXD3 is a mutant BRAF- regulated inhibitor of G1/S progression in melanoma cells. Cancer Res, 70, 2891-2900 (2010)
51. J. Xu, J. A. Watts, S. D. Pope, P. Gadue, M. Kamps, K. Plath, K. S. Zaret and S. T. Smale: Transcriptional competence and the active marking of tissue-specific enhancers by defined transcription factors in embryonic and induced pluripotent stem cells. Genes Dev, 23, 2824-2838 (2009)
52. G. Pan, J. Li, Y. Zhou, H. Zheng and D. Pei: A negative feedback loop of transcription factors that controls stem cell pluripotency and self-renewal. FASEB J, 20, 1730-1732 (2006)
53. G. Pan and J. A. Thomson: Nanog and transcriptional networks in embryonic stem cell pluripotency. Cell Res, 17, 42-49 (2007) (Pubitemid 46096423)
54. M. Y. Lee, H. W. Lim, S. H. Lee and H. J. Han: Smad, PI3K/Akt, and Wnt-dependent signaling pathways are involved in BMP-4-induced ESC self-renewal. Stem Cells, 27, 1858-1868 (2009)